Interleukin-17 cytokines: Effectors and targets in psoriasis—A breakthrough in understanding and treatment

Abstract

This review summarizes the steps from basic research on IL-17 family cytokines to understanding their role in psoriasis pathogenesis to the approval of a number of monoclonal antibodies targeting IL-17 pathways as first line treatment of psoriasis and psoriatic arthritis.